Simply Wall St.
Is It Too Late To Consider Natera After Its Recent 12.8% Price Surge?
📊
AI Sentiment
Positive
6/10
Natera Inc. News
Latest updates and market news for NTRA
5 news
Dec 7 - Dec 13, 2025
Page 1
Business Wire
Phase III PALLAS Study Shows Signatera™ MRD Testing Provides Powerful Post‑Surgical Prognostic Information in Patients with High and Intermediate Risk HR+/HER2‑ Breast Cancer
📈
AI Sentiment
Highly Positive
8/10
MedTech Dive
Natera acquires Foresight Diagnostics for up to $450M
📈
AI Sentiment
Highly Positive
8/10
Business Wire
Natera Highlights New Findings in Lymphoma at the ASH Annual Meeting
📈
AI Sentiment
Highly Positive
9/10
Medical Device Network
Natera purchases Foresight Diagnostics
📈
AI Sentiment
Highly Positive
8/10
Share this news page